177 related articles for article (PubMed ID: 33454931)
1. Primary aldosteronism: considerations about the evaluation of the aldosterone to renin ratio during canrenone treatment.
Armanini D; Sabbadin C; Boscaro M
J Endocrinol Invest; 2021 Sep; 44(9):2009-2010. PubMed ID: 33454931
[No Abstract] [Full Text] [Related]
2. Mineralocorticoid Receptor Antagonist Effect on Aldosterone to Renin Ratio in Patients With Primary Aldosteronism.
Pecori A; Buffolo F; Burrello J; Mengozzi G; Rumbolo F; Avataneo V; D'Avolio A; Rabbia F; Bertello C; Veglio F; Mulatero P; Monticone S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3655-e3664. PubMed ID: 33942084
[TBL] [Abstract][Full Text] [Related]
3. Effects of Mineralocorticoid and AT1 Receptor Antagonism on The Aldosterone-Renin Ratio In Primary Aldosteronism-the EMIRA Study.
Rossi GP; Ceolotto G; Rossitto G; Maiolino G; Cesari M; Seccia TM
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32067030
[TBL] [Abstract][Full Text] [Related]
4. Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism.
Seifarth C; Trenkel S; Schobel H; Hahn EG; Hensen J
Clin Endocrinol (Oxf); 2002 Oct; 57(4):457-65. PubMed ID: 12354127
[TBL] [Abstract][Full Text] [Related]
5. Confirmatory testing in primary aldosteronism: extensive medication switching is not needed in all patients.
Solar M; Malirova E; Ballon M; Pelouch R; Ceral J
Eur J Endocrinol; 2012 Apr; 166(4):679-86. PubMed ID: 22253400
[TBL] [Abstract][Full Text] [Related]
6. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism.
Weiner ID
Semin Nephrol; 2013 May; 33(3):265-76. PubMed ID: 23953804
[TBL] [Abstract][Full Text] [Related]
7. Adrenal Vein Sampling Lateralization Despite Mineralocorticoid Receptor Antagonists Exposure in Primary Aldosteronism.
Nanba AT; Wannachalee T; Shields JJ; Byrd JB; Rainey WE; Auchus RJ; Turcu AF
J Clin Endocrinol Metab; 2019 Feb; 104(2):487-492. PubMed ID: 30239792
[TBL] [Abstract][Full Text] [Related]
8. Primary aldosteronism: the most frequent form of secondary hypertension?
Shargorodsky M; Zimlichman R
Isr Med Assoc J; 2002 Jan; 4(1):32-3. PubMed ID: 11802308
[No Abstract] [Full Text] [Related]
9. Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone-renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design.
Rossitto G; Cesari M; Ceolotto G; Maiolino G; Seccia TM; Rossi GP
J Hum Hypertens; 2019 Feb; 33(2):167-171. PubMed ID: 30518805
[TBL] [Abstract][Full Text] [Related]
10. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
11. [Conn syndrome as cause of stubborn hypertension. Which hypertensives should you screen?].
Reincke M
MMW Fortschr Med; 2003 Feb; 145(9):37-40. PubMed ID: 12666528
[No Abstract] [Full Text] [Related]
12. Primary aldosteronism: diagnostic and treatment strategies.
Mattsson C; Young WF
Nat Clin Pract Nephrol; 2006 Apr; 2(4):198-208; quiz, 1 p following 230. PubMed ID: 16932426
[TBL] [Abstract][Full Text] [Related]
13. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
14. Ambulatory blood pressure parameters after canrenone addition to existing treatment regimens with maximum tolerated dose of angiotensin-converting enzyme inhibitors/angiotensin II type 1 receptor blockers plus hydrochlorothiazide in uncontrolled hypertensive patients.
Guasti L; Gaudio G; Lupi A; D'Avino M; Sala C; Mugellini A; Vulpis V; Felis S; Sarzani R; Vanasia M; Maffioli P; Derosa G
Drug Des Devel Ther; 2017; 11():2293-2300. PubMed ID: 28831241
[TBL] [Abstract][Full Text] [Related]
15. Lessons from Africa: the importance of measuring plasma renin and aldosterone in resistant hypertension.
Spence JD
Can J Cardiol; 2012 May; 28(3):254-7. PubMed ID: 22289470
[No Abstract] [Full Text] [Related]
16. Some considerations about evolution of idiopathic primary aldosteronism.
Armanini D; Fiore C
J Endocrinol Invest; 2009 Jul; 32(7):623-5. PubMed ID: 19893360
[TBL] [Abstract][Full Text] [Related]
17. Primary aldosteronism, diagnosed by the aldosterone to renin ratio, is a common cause of hypertension.
Lim PO; MacDonald TM
Clin Endocrinol (Oxf); 2003 Oct; 59(4):427-30. PubMed ID: 14510903
[No Abstract] [Full Text] [Related]
18. Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism.
Mulatero P; Rabbia F; Milan A; Paglieri C; Morello F; Chiandussi L; Veglio F
Hypertension; 2002 Dec; 40(6):897-902. PubMed ID: 12468576
[TBL] [Abstract][Full Text] [Related]
19. The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.
Niizuma S; Nakahama H; Kamide K; Fukuchi K; Iwanaga Y; Nakata H; Yoshihara F; Horio T; Nakamura S; Kawano Y
Clin Exp Hypertens; 2008 Oct; 30(7):640-7. PubMed ID: 18855267
[TBL] [Abstract][Full Text] [Related]
20. Unadjusted Plasma Renin Activity as a "First-Look" Test to Decide Upon Further Investigations for Primary Aldosteronism.
Rye P; Chin A; Pasieka J; So B; Harvey A; Kline G
J Clin Hypertens (Greenwich); 2015 Jul; 17(7):541-6. PubMed ID: 25756935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
